Time for tocilizumab in COVID-19?

Intensive Care Med. 2021 Jun;47(6):692-694. doi: 10.1007/s00134-021-06441-y. Epub 2021 May 31.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab